Serum miR-1290 as a marker of pancreatic cancer-letter

Clinical Cancer Research

Volumn 19, Issue 18, 2013, Pages 5250-5251

  Frampton, Adam E ^a   Krell, Jonathan ^b   Kazemier, Geert ^c   Giovannetti, Elisa ^d  

^a Hammersmith Hospital Campus   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 1290; MICRORNA 16; MICRORNA 21; MICRORNA 486 3P; UNCLASSIFIED DRUG;

BLOOD LEVEL; CANCER PROGNOSIS; CANCER STAGING; ERYTHROCYTE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; LETTER; NONHUMAN; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; UPREGULATION;

HUMANS; MICRORNAS; PANCREATIC NEOPLASMS; TRANSCRIPTOME;

EID: 84884563150     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-13-1620     Document Type: Letter

References (6)

1. Li A, Yu J, Wolfgang CL, Canto M, Hruban RH, Goggins M, et al. MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls. Clin Cancer Res. 2013;19:3600-10
2. Baraniskin A, Nöpel-Dünnebacke S, Ahrens M, Jensen SG, Zöllner H, Maghnouj A, et al. Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for pancreatic and colorectal adenocarcinoma. Int J Cancer 2013;132:E48-57.
3. Pritchard CC, Kroh E, Wood B, Arroyo JD, Dougherty KJ, Miyaji MM, et al. Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev Res 2012;5:492-7.
4. Liu J, Gao J, Du Y, Li Z, Ren Y, Gu J, et al. Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer. Int J Cancer 2012;131:683-91.
5. Wang WS, Liu LX, Li GP, Chen Y, Li CY, Jin DY, et al. Combined serum CA19-9 and miR-27a-3p in peripheral blood mononuclear cells to diagnose pancreatic cancer. Cancer Prev Res 2013;6:331-8.
6. Liu R, Chen X, Du Y, Yao W, Shen L, Wang C, et al. Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer. Clin Chem 2012;58:610-8.